Cliniphar Co., Ltd. (432A) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cliniphar Co., Ltd. (432A:JPX), powered by AI.

Current Price
¥1,450
Sector
Healthcare
What is the Cliniphar Co., Ltd. stock price forecast?

Cliniphar Co., Ltd. is currently trading at ¥1,450. View real-time AI analysis on Alpha Lenz.

What is Cliniphar Co., Ltd. insider trading activity?

View the latest insider trading data for Cliniphar Co., Ltd. on Alpha Lenz.

What is Cliniphar Co., Ltd.'s P/E ratio?

View Cliniphar Co., Ltd.'s valuation metrics on Alpha Lenz.

Cliniphar Co., Ltd.

JPX · 432A
¥1,450Market closedJPX regular session 09:00–15:00 JST
Ask about Cliniphar Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Cliniphar Co., Ltd.'s ROE is 20.2%. Explore profitability and growth together.

Ask for details

Company Overview

Cliniphar Co., Ltd. is a holding company specializing in the wholesale and distribution of pharmaceuticals within both domestic Japanese and international markets. Established in 2017, it plays a pivotal role in advancing healthcare logistics by integrating subsidiaries and leveraging synergies across the healthcare industry, with a focus on delivering efficiency and innovation to pharmaceutical distribution. Cliniphar manages a substantial portfolio, distributing more than 17,000 prescription products and collaborating with approximately 12,000 healthcare professionals and institutions. The company operates B2B e-commerce platforms designed for healthcare providers, such as Kosei Market, and maintains digital drug databases such as Synapse, supporting both the Japanese and global medical sectors. Located in Osaka, Cliniphar aims to streamline drug supply chains, ensuring prompt and stable access to a broad range of pharmaceuticals for hospitals, clinics, and pharmacies. Its market presence underscores its significance as a facilitator of supply chain innovation and reliability, serving as an essential intermediary in the healthcare ecosystem.

SectorHealthcare
IndustryPharmaceutical Retailers
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
¥3,585,611,000Revenue
0.00Shares Out
0Employees

Margins

18.54%Gross
5.97%EBITDA
4.12%Operating
5.55%Pre-Tax
5.31%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

7.70%ROA
20.19%ROE
8.32%ROIC

Financial Health

¥1,142,519,000Cash & Cash Equivalents
¥503,469,000Net Debt
162.00%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Cliniphar Co., Ltd. (ticker: 432A) is a company listed on JPX in the Healthcare sector (Pharmaceutical Retailers).

The current price is 1,450 with a P/E ratio of -x and P/B of -x.

ROE is 20.19% and operating margin is 4.12%. Annual revenue is $3.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Cliniphar Co., Ltd. (432A) Stock Forecast 2026 ¥1,450 — Price, Financials & Analyst Targets | Alpha Lenz